Short answer
CATALYST PHARMACEUTICALS, INC. (CPRX) filed an 8-K current report with the SEC on February 25, 2026 reporting Item 8.01 (Other Events). Q4 and full-year 2025 earnings results disclosed alongside 2026 revenue guidance: details in Exhibit 99.1.
CATALYST PHARMACEUTICALS, INC. 8-K event analysis
AI summary of each reported item and its exhibits
Item 8.01 · Other Events
- Q4 and full-year 2025 earnings results disclosed alongside 2026 revenue guidance: details in Exhibit 99.1
- 2026 revenue guidance issuance signals management visibility into pipeline/commercial trajectory, a key catalyst for CPRX investors
- Full financial figures require review of attached press release (Exhibit 99.1)
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other CATALYST PHARMACEUTICALS, INC. 8-K filings
Get the next CPRX 8-K as it lands
Follow CPRX for push alerts, or ask the research agent what this filing means.